RB, the global consumer health, hygiene and home company, has appointed Wieden+Kennedy on the Nurofen business globally after a review process which included McCann Erickson and incumbent, Havas.

Roberto Funari, Executive Vice President global category development, says ‘We are delighted that Wieden+Kennedy will be partnering with us on this key brand.  The quality of the strategic and creative thinking we have seen throughout the review has been superb”.